Many generic anthelmintics are commercially available; however, very little information exists regarding effectiveness of these products compared with pioneer brands. Therefore, the objective of this study was to conduct a… Click to show full abstract
Many generic anthelmintics are commercially available; however, very little information exists regarding effectiveness of these products compared with pioneer brands. Therefore, the objective of this study was to conduct a fecal egg count reduction test comparing generic eprinomectin (Eprizero) to pioneer eprinomectin (Eprinex), as well as to fenbendazole in grazing beef steers. Naturally infected steers (n = 40; BW = 212±5 kg) were allocated into five treatment groups based on ranked fecal egg counts:. Eprinex (EX), 2. Eprizero (EZ), 3. Safeguard (SG), 4. Eprinex + Safeguard (XS), or 5. Control/No treatment (NT). Fecal samples were collected on days -7, 0, 14, and 29, and body weights were recorded on days -14 and 29. Data were analyzed using the MIXED procedure of SAS 9.4. At day 14 post-treatments, the EX treatment group demonstrated a 50% fecal egg count reduction (FECR), while EZ treatment group had a 79% FECR. Both the SG and XS treatment groups showed a 98% and 100% FECR, respectively. At day 29 post-treatment, EX and EZ treatment groups demonstrated a1% and 5% FECR, while the SG and XS treatment groups displayed a 94% and 89% FECR. The coproculture data indicated that Cooperia punctata, Cooperia oncophora and Ostertagia ostertagi all persisted and comprised at least 90% of the larvae recovered from both the EX and EZ coprocultures performed on days 14 and 29. Haemonchus spp. was recovered from EZ coprocultures on days 14 and 29 (10% and 1%, respectively, of recovered larvae), as well as from the EX coprocultures (4% and%, respectively). Interestingly, the proportions of C. punctata and C. oncophora essentially demonstrated a post-treatment reversal in the both the SG and XS treatment groups when comparing days 0 and 29, possibly indicating a greater efficacy of fenbendazole against than C. punctata. There were no significant differences (P < 0.05) in average daily gains between the treatment groups.
               
Click one of the above tabs to view related content.